Morgan Stanley Downgrades Arm Holdings to Equalweight

1 min read Reproduced verbatim
Rating
Equalweight
Downgraded
Target
$150
from $135 (+11%)
Outcome
Reached
on April 13, 2026
Morgan Stanley and Arm logos

What the analyst said

Morgan Stanley analyst Lee Simpson downgraded Arm Holdings (NASDAQ: ARM) from Overweight to Equalweight with a price target of $150.00 (from $135.00).

“Arm’s transition into chip making marks a structural evolution of its business model, aligned with the emergence of agentic AI.

In an agentic world, GPUs (graphics processing units) generate and reason, while central processing units (CPUs) coordinate and execute.

Always on, power-efficient CPUs therefore retain strategic relevance.

Arm’s new AGI-oriented CPU design (specifically built for agentic AI workloads) demonstrates that the CPU is far from obsolete and reinforces the long-term rationale for deeper vertical integration (link).

Arm’s talent acquisition, strategic positioning, and early design delivery have been exemplary.

However, the commercial ramp will take time, and near-term risks temper enthusiasm.

Post announcement, we think investor focus is likely to revert to Arm’s in-line guide against a challenging demand backdrop.

End market softness, compounded by DRAM supply constraints, could stymie near-term growth (FY27e).

Margin dynamics are also in flux, with elevated R&D/engineering costs ahead of meaningful chip revenues. In addition, Arm’s entry into silicon increases the risk of channel conflict.

Competing – directly or indirectly – with parts of its licensee base introduces the possibility of customer pushback, which we’d argue investors should not discount.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ARM trades at $197. The 2 analysts who set a target in the last 3 months range from $320 to $641, with a median of $481. This $150 target is 69% below the median, the lowest on the Street.

Since the note ARM has moved +32% (from $149). 12-month window: day 209 of 365, closes on April 7, 2027.

Track record

This call✓ Target reached on April 13, 2026, 6 days after the note.

Firm track recordMorgan Stanley: 81% of its 48 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →

Morgan Stanley on Arm

Morgan Stanley price targets on Arm

5 calls from January 23, 2026 to July 30, 2026. The target went from $180 to $212 (+18%). The rating moved from Buy to Hold.

Morgan Stanley targetARM share price
  1. July 30, 2026Target raised from $202 (+5%)Hold$212
  2. May 7, 2026Target raised from $191 (+6%)Hold$202
  3. May 1, 2026Target raised from $150 (+27%)Hold$191
  4. April 7, 2026 This noteDowngraded to Hold, target cut from $180 (−17%)Hold$150
  5. January 23, 2026Earliest call shownBuy$180
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.